Citation:Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA 2007

From Cancer Guidelines Wiki

Citation


Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 2007 Apr 15;109(8):1668-75 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17342770.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA 2007What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?
  2. What is the role of prophylactic cranial irradiation (PCI) in patients with stage III NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Chen_AM,_Jahan_TM,_Jablons_DM,_Garcia_J,_Larson_DA_2007&oldid=21444"